Category: Pharmaceuticals

Human Milk Oligosaccharides (HMO) Market Overview, Industry Top Manufactures, Size, Growth rate 2018 ? 2023

Human Milk Oligosaccharides (HMO) market report gives attention to market segmentation, market size, and forecast of 2018-2023 to help stakeholders in making a good decision for the future investments. Human Milk Oligosaccharides (HMO) industry report segmented into types, application, and regions with providing production, revenue, import/export. The Human Milk Oligosaccharides …

Extracorporeal Shock Wave Lithotripsy Machine Market Overview, Growth Forecast, Demand and Development Research Report to 2023

Global Extracorporeal Shock Wave Lithotripsy Machine Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Extracorporeal Shock Wave Lithotripsy Machine research report is a professional and in-depth …

Dynamic Blood Pressure Monitor Consumption Market Size 2023 – Global Industry Sales, Revenue, Price trends and more

According to Market Study Report, Dynamic Blood Pressure Monitor Market provides a comprehensive analysis of the Dynamic Blood Pressure Monitor market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities of global industry. This report also provides market landscape and market share information in …

Bilirubin Meters Consumption Market Global Briefing and Future Outlook 2018 to 2023

Market Study Report add Global Bilirubin Meters market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key …

Eli Lilly launches Olumiant in India, forays into autoimmune segment

The U.S. based pharmaceutical firm Eli Lilly and Company has reportedly announced to have forayed in the autoimmune segment in India. As per trusted sources, the drug maker has launched a new once-daily oral therapy, named as Olumiant, to treat rheumatoid arthritis. Reportedly, OlumiantTM is an advanced and effective once-daily …

Cannabis firm MedMen acquires PharmaCann worth USD 682 million

Los Angeles-based cannabis firm, MedMen Enterprises Inc. has recently announced its binding letter of intent to acquire the Illinois-based medical cannabis provider PharmaCann LLC for a valuation of USD 682 million. With thus takeover, MedMen will be expanding its reach with 79 licensed cannabis facilities amid growing operations in 12 …

CVS and Aetna’s megamerger worth $69 billion wins DOJ approval

U.S. retail drugstore chain, CVS Health Corp. has recently won approval of a $69 billion acquisition of healthcare insurer Aetna, Inc. by the U.S. Department of Justice (DOJ), paving the way for a merger that can cut health care costs for consumers. Sources close to the matter suggest merger of …

Health Canada bans valsartan from Chinese manufacturing unit

Health Canada, the government department responsible for national public health, in its recent announcement unveiled that it has found the manufacturing site of Chinese drug Zhejiang Huahai Pharmaceuticals to be non-compliant with the requirements of GMPs (Good Manufacturing Practices). GMPs, for the record, are international standards that help ensure that …